Clinically, BC is often divided into different subtypes depending on the expression of ER, PR, and HER2 receptors; they are important indicators for the selection of treatment methods, evaluation of malignancy, and prediction of prognosis.48 The gene discussed is PGR; the disease is breast cancer.